{"id":"W3115800286","doi":"10.4049/immunohorizons.2000089","title":"Enhanced Immunotherapeutic Efficacy of Anti–PD-L1 Antibody in Combination with an EP4 Antagonist","year":2020,"lang":"en","type":"article","venue":"ImmunoHorizons","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bio-oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science; National Agriculture and Food Research Organization; Ministry of Agriculture - Saskatchewan","keywords":"Blockade; Downregulation and upregulation; Immunotherapy; PD-L1; Cancer research; Cancer immunotherapy; Tumor necrosis factor alpha; T cell; Immune system; Pharmacology; Chemistry; Cytokine; Medicine; Receptor; Immunology; Biochemistry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001797728,0.0003698554,0.0004916012,0.000342181,0.0001043598,0.0002737089,0.0002537235,0.0002899272,0.001161288],"category_scores_gemma":[0.0001083024,0.0001000141,0.0002477844,0.0001633239,0.0001804635,0.0002209227,0.0002047227,0.0008624578,0.0002393386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002052195,"about_ca_system_score_gemma":0.0001763704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002732281,"about_ca_topic_score_gemma":0.0003582588,"domain_scores_codex":[0.9998639,0.00003211503,0.00001065765,0.00001722474,0.00003069413,0.00004539695],"domain_scores_gemma":[0.9999416,0.00001358526,0.00001227953,0.000007114892,0.000006030205,0.00001937031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002057336,0.001095875,0.0002517106,0.0001388417,0.00004635775,0.00008604743,0.00002120489,0.0006020434,0.9785014,0.0001628948,0.000240124,0.01679634],"study_design_scores_gemma":[0.0005200096,0.01584953,0.002554417,0.00001473584,0.0001322944,0.0003955779,0.00002198172,0.003467541,0.9712702,0.00008326209,0.005679644,0.00001079673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931442,0.002706205,0.002454912,0.0001189758,0.00009295956,0.00006412905,0.00009752323,0.00006375961,0.001257452],"genre_scores_gemma":[0.995809,0.0009760281,0.001681231,0.00007055351,0.00004613779,0.00005717761,0.0001325314,0.000008162778,0.001219202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001161288,"threshold_uncertainty_score":0.003884852,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01821717098683972,"score_gpt":0.3055320010749877,"score_spread":0.287314830088148,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}